Brief: Unity Biotechnology Q3 Operating Income USD -14.931 Million
13/11/2023 21:05
Nov 13 (Reuters) - Unity Biotechnology Q3 basic EPS USD -1.05. * Q3 operating expenses USD 14.931 million * Q3 net income USD -15.289 million
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force